253 assets in Diffuse Large B-Cell Lymphoma

Therapeutic assets addressing Diffuse Large B-Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Sasanlimab Diffuse Large B-Cell Lymphoma	Pfizer	P1	D (28)
Obutinib Diffuse Large B-Cell Lymphoma	Mingzhi Zhang	P1/2	NR ()
trs005 Diffuse Large B-Cell Lymphoma	Zhejiang Teruisi Pharmaceutical Inc.	P2	NR ()

Showing 251 to 253 of 253 assets

PreviousPage 6 of 6Next